Cargando…
Nanozymes in Tumor Theranostics
Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural e...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560966/ https://www.ncbi.nlm.nih.gov/pubmed/34737942 http://dx.doi.org/10.3389/fonc.2021.666017 |
_version_ | 1784593033401991168 |
---|---|
author | Ma, Qiulian Liu, Yanfang Zhu, Haitao Zhang, Lirong Liao, Xiang |
author_facet | Ma, Qiulian Liu, Yanfang Zhu, Haitao Zhang, Lirong Liao, Xiang |
author_sort | Ma, Qiulian |
collection | PubMed |
description | Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural enzymes, such as easy inactivation, high cost, and low yield. With the development of more and more smart and multi-functional nanosystems, nanozymes display great achievement in tumor biology. In this review, we outline the recent advances of nanozymes in tumor and tumor microenvironment diagnosis, therapy, and theranostics. |
format | Online Article Text |
id | pubmed-8560966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85609662021-11-03 Nanozymes in Tumor Theranostics Ma, Qiulian Liu, Yanfang Zhu, Haitao Zhang, Lirong Liao, Xiang Front Oncol Oncology Nanozymes, a new generation of enzyme mimics, have recently attracted great attention. Nanozymes could catalyze chemical reactions as biological enzymes under physiologically mild conditions with higher-efficiency catalytic activities. Moreover, nanozymes could overcome the shortcomings of natural enzymes, such as easy inactivation, high cost, and low yield. With the development of more and more smart and multi-functional nanosystems, nanozymes display great achievement in tumor biology. In this review, we outline the recent advances of nanozymes in tumor and tumor microenvironment diagnosis, therapy, and theranostics. Frontiers Media S.A. 2021-10-19 /pmc/articles/PMC8560966/ /pubmed/34737942 http://dx.doi.org/10.3389/fonc.2021.666017 Text en Copyright © 2021 Ma, Liu, Zhu, Zhang and Liao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Ma, Qiulian Liu, Yanfang Zhu, Haitao Zhang, Lirong Liao, Xiang Nanozymes in Tumor Theranostics |
title | Nanozymes in Tumor Theranostics |
title_full | Nanozymes in Tumor Theranostics |
title_fullStr | Nanozymes in Tumor Theranostics |
title_full_unstemmed | Nanozymes in Tumor Theranostics |
title_short | Nanozymes in Tumor Theranostics |
title_sort | nanozymes in tumor theranostics |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560966/ https://www.ncbi.nlm.nih.gov/pubmed/34737942 http://dx.doi.org/10.3389/fonc.2021.666017 |
work_keys_str_mv | AT maqiulian nanozymesintumortheranostics AT liuyanfang nanozymesintumortheranostics AT zhuhaitao nanozymesintumortheranostics AT zhanglirong nanozymesintumortheranostics AT liaoxiang nanozymesintumortheranostics |